Intensified Neoadjuvant Therapy Improves Outcomes in Very High-Risk Prostate Cancer
Investigators compared ADT plus abiraterone or docetaxel with ADT alone.
Investigators compared ADT plus abiraterone or docetaxel with ADT alone.
Major effects of febuxostat on renal outcome might be uric acid dependent, according to investigators.
Incorporating a combination of urinary biomarkers may help identify patients at the highest risk for CKD progression.
Investigators reviewed the latest studies examining the association between BCG administration and the risk of Alzheimer disease and other dementia in patients with bladder cancer.
Trajectories of key clinical variables associated with weight loss distinguished patients with physiologic resilience vs vulnerability.
Inorganic nitrate also reduced the risk for major adverse cardiac events in patients undergoing coronary angiography for non-ST-elevation acute coronary syndrome.
Treatment with the glucagon-like-peptide-1 receptor agonist yielded substantial benefits in patients with heart failure with preserved ejection fraction.
Biochemical recurrence endpoints did not reliably predict overall survival in prostate cancer trials.
Mean testosterone concentration was relatively stable until age 70 years, investigators reported.
Patients with prostate cancer who have visceral metastases limited to the lung have the best prognosis.